MedTrace Logo

LEVITRA® 20mg Special Drug Use Investigation (Long-term)

NCT00909233 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1221

Last updated 2014-12-15

No results posted yet for this study

Summary

This investigation targets either the patients of 18 years-old or older and under 65 years-old with organic or mixed erectile dysfunction (ED) who cannot obtain sufficient efficacy by dose 10mg of Levitra, and the target patients dose is increased to Levitra 20mg. This investigation will be limited to the patients whose tolerability of Levitra 10mg is judged to be no problem.

Conditions

Interventions

DRUG

Vardenafil, (Levitra, BAY38-9456)

Patients under daily life treatment receiving Levitra according to local drug information.

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2010-03-31
Completion
2011-12-31

Countries

  • Japan

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00909233 on ClinicalTrials.gov